Kidney disease biobank aims to unlock new treatments

NCT ID NCT04174066

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting blood, urine, and kidney tissue samples from 144 children and adults with a kidney condition called nephrotic syndrome. The goal is to build a large database and sample collection to study how the immune system and kidney cells interact. Researchers hope this will help find new treatment targets and reduce reliance on steroids and other drugs with many side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify new drug targets for nephrotic syndrome, potentially leading to more effective treatments with fewer side effects.
What could go wrong: This is an observational biobank study, not a treatment trial. It may not directly lead to new therapies, and results may take years to translate into clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC NEPHROTIC SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic nephrotic syndrome lipoid nephrosis nephrotic syndrome primary focal segmental glomerulosclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEPHROTIC SYNDROME

Contacts and locations

Locations

APHP
RECRUITING

Paris, 75000, France
Nice Hospital
RECRUITING

Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.